Rubius Therapeutics, Inc.
RUBY
Revenue
0.00
0.000.00%
3 Months ChangeAssets
23.07M
▼-147.63M▼-86.48%
3 Months ChangeLiabilities
7.94M
▼-126.17M▼-94.08%
3 Months ChangeFree Cash Flow
-49.54M
▼-10.05M▼-25.45%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-04-06
Form 8-K
ID: 0001104659-23-042792
2023-03-03
Form 8-K
ID: 0001104659-23-028428
2023-02-22
Form 8-K
ID: 0001104659-23-024013
2023-02-06
Form 8-K
ID: 0001104659-23-011161
2022-12-21
Form 8-K
ID: 0001104659-22-129159
2022-12-14
Form 8-K
ID: 0001104659-22-127005
2022-12-12
Form 8-K
ID: 0001104659-22-126268
2022-11-09
Form 10-Q
ID: 0001709401-22-000019
2022-11-02
Form 8-K
ID: 0001104659-22-113964
2022-10-17
Form 8-K
ID: 0001104659-22-109319